Antibacterial efficacy of ciprofloxacin in a case of endocarditis due to Cardiobacterium hominis.
Endocarditis due to Cardiobacterium hominis is rare and may be treated with a variety of antibiotics. We isolated the bacteria from blood cultures of a patient with Cardiobacterium hominis endocarditis who could be successfully treated with ciprofloxacin. The bacterial features of Cardiobacterium hominis are presented, and susceptibility to ciprofloxacin is documented with bacterial killing curves employing peak and trough specimens of patient's serum.
Vogt
K
K
Department of Medical Microbiology, Rudolf Virchow University Hospital, Berlin.
Klefisch
F
F
Hahn
H
H
Schmutzler
H
H
D000328:Adult; D001421:Bacteria, Anaerobic / Q000187:drug effects; D001770:Blood Bactericidal Activity; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D006090:Gram-Negative Bacteria / Q000187:drug effects; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests
D002939:Ciprofloxacin